Across Kenya, a familiar scenario unfolds in homes, chemists, and clinics: a child develops a mild fever or cough, a parent purchases antibiotics over the counter without a prescription, and the treatment is stopped once the child shows improvement. While this may seem harmless, public health experts warn that such practices are quietly fueling one of Kenya’s most dangerous medical crises: antimicrobial resistance (AMR).
What Is Antimicrobial Resistance?
AMR occurs when bacteria, viruses, or fungi evolve to resist the drugs designed to kill them, making infections harder or even impossible to treat. Misuse of antibiotics, incomplete courses, self-prescription, and lack of laboratory testing all accelerate this process. In Kenya, antibiotics are often obtained without prescription, doses are stopped prematurely, and leftover tablets are saved for future illnesses a combination that allows bacteria to survive, mutate, and resist standard treatments.
The Waning Power of Antibiotics
Once hailed as “wonder drugs” by the World Health Organization in the 1940s, antibiotics transformed medicine, making infections treatable, surgeries safer, and childbirth less deadly. Today, life-saving antibiotics are losing their efficacy. According to WHO data, one in five bacterial infections globally no longer responds to commonly used antibiotics. Dangerous pathogens such as E. coli and Klebsiella, responsible for severe blood infections, are increasingly resistant to critical treatments including third-generation cephalosporins. The result: infections that once cleared in days now linger, recur, and in some cases, prove fatal.
Impact on Hospitals and Families
In Busia County, clinical nurse Esther Anzaye witnesses the consequences firsthand:
“Patients with resistant infections spend a lot on treatment, from diagnostics to the appropriate antibiotics. They stay longer in hospital and take more time to heal.”
Longer hospital stays increase the risk of hospital-acquired infections and place enormous financial and operational strain on healthcare facilities. Dr. Silvano Katayi, a clinical pharmacist and AMR focal person in Busia, notes that resistance often begins when patients stop medications too soon, exposing bacteria to sub-therapeutic doses and allowing them to evolve.
Self-prescription is another major driver. Many Kenyans demand antibiotics for viral infections, such as the common cold or flu, for which antibacterial drugs are ineffective.
“Common cold is viral and usually self-limiting. Using antibiotics in such cases exposes patients to side effects without any benefit,” Dr. Katayi explains.
The Household Factor: Sharing and Convenience
In many homes, leftover antibiotics are shared among children or family members, with dosages guessed and courses shortened. Different antibiotics target specific infections, and misuse allows bacteria to survive and develop resistance. Convenience and cost further exacerbate the problem: visiting a hospital requires time, consultation fees, and laboratory tests, whereas obtaining drugs from a chemist is quicker and cheaper.
Although Kenyan law mandates that antibiotics be dispensed only with a prescription under the Pharmacy and Poisons Board, enforcement remains weak, and competition among chemists often undermines compliance.
The Science of Effective Antibiotic Use
AMR is prevented not only by completing prescribed courses but also by proper testing, timing, and dosing. Culture and sensitivity tests are essential to determine which antibiotics are effective, while correct dosing ensures that the drug maintains the minimum inhibitory concentration, the level required to stop bacterial growth. Deviations in timing or dosage can allow resistant bacteria to flourish, leading to recurrent infections that require stronger, often more expensive, treatments.
Economic and Healthcare Consequences
When infections become resistant, doctors must resort to broad-spectrum antibiotics that are more costly and can disrupt beneficial bacterial flora, increasing susceptibility to other infections. Patients face higher diagnostic costs and longer hospital stays, while the healthcare system bears the burden of rising treatment demands. AMR threatens not only individual health but also essential medical procedures such as surgeries, cancer treatments, and maternal care, putting decades of medical progress at risk.
Fighting Back Against AMR
Combating AMR requires a coordinated, multidisciplinary approach involving surveillance, public education, and strict adherence to treatment guidelines. Pharmacists, clinicians, and health workers must work together to:
- Select the correct drug
- Adjust doses based on age and organ function
- Apply de-escalation protocols, starting broad and narrowing treatment once lab results confirm effectiveness
Continuous medical education and adherence to WHO and One Health guidelines, which recognize the interconnectedness of humans, animals, and the environment in spreading resistance, are crucial.
A Call to Action
AMR begins at home, with incomplete doses, shared medications, and unnecessary purchases. Every misuse allows bacteria to adapt. Every prematurely stopped course makes future infections harder to treat.
Antibiotics can remain powerful allies in medicine or become relics of an era we failed to protect. The next time a child improves after a short course of medication, the choice to complete treatment could determine not just one recovery, but the future of medicine itself.
